Noonan syndrome - a new survey.

Authors:
Peyman Eshraghi
Peyman Eshraghi
Mashhad University of Medical Sciences
Mashhad | Iran
Zahra Kamel Koleti
Zahra Kamel Koleti
Shohada Hospital
Tehran | Iran
Mohammadreza Abbaszadegan
Mohammadreza Abbaszadegan
Immunology Research Center

Arch Med Sci 2017 Feb 19;13(1):215-222. Epub 2016 Dec 19.

Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Noonan syndrome (NS) is an autosomal dominant disorder with vast heterogeneity in clinical and genetic features. Various symptoms have been reported for this abnormality such as short stature, unusual facial characteristics, congenital heart abnormalities, developmental complications, and an elevated tumor incidence rate. Noonan syndrome shares clinical features with other rare conditions, including LEOPARD syndrome, cardio-facio-cutaneous syndrome, Noonan-like syndrome with loose anagen hair, and Costello syndrome. Germline mutations in the RAS-MAPK (mitogen-activated protein kinase) signal transduction pathway are responsible for NS and other related disorders. Noonan syndrome diagnosis is primarily based on clinical features, but molecular testing should be performed to confirm it in patients. Due to the high number of genes associated with NS and other RASopathy disorders, next-generation sequencing is the best choice for diagnostic testing. Patients with NS also have higher risk for leukemia and specific solid tumors. Age-specific guidelines for the management of NS are available.

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2017.64720DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206377PMC
February 2017
3 Reads

Publication Analysis

Top Keywords

noonan syndrome
16
clinical features
8
syndrome
7
mitogen-activated protein
4
protein kinase
4
ras-mapk mitogen-activated
4
mutations ras-mapk
4
germline mutations
4
kinase signal
4
pathway responsible
4
disorders noonan
4
syndrome diagnosis
4
responsible disorders
4
syndrome germline
4
transduction pathway
4
signal transduction
4
hair costello
4
leopard syndrome
4
syndrome cardio-facio-cutaneous
4
including leopard
4

Similar Publications

Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.

Am J Med Genet A 2016 Oct 7;170(10):2570-7. Epub 2016 May 7.

Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Canada.

Noonan, Cardio-facio-cutaneous, and Costello syndromes are disorders of the Ras/MAPK pathway that share many clinical features. This observational and anthropometric study was conducted to describe the key facial features of each syndrome in order to improve discrimination between the three conditions, particularly in young children where diagnosis is most challenging. Direct measurement of the head and face was used to enhance diagnostic accuracy, and identify the most unusual or specific dimensions. Read More

View Article
October 2016

Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.

Expert Rev Mol Med 2008 Dec 9;10:e37. Epub 2008 Dec 9.

Department of Anatomy, University of California San Francisco, CA 94115, USA.

A class of developmental disorders caused by dysregulation of the Ras-induced mitogen-activated protein kinase (MAPK) cascade (the Ras-MAPK pathway) has emerged. Three of these disorders - Noonan, Costello and cardio-facio-cutaneous syndromes - have overlapping phenotypic features characterised by distinctive facial dysmorphia, cardiac defects, musculoskeletal and cutaneous abnormalities, and neurocognitive delay. The germline mutations associated with these disorders are in genes that encode proteins of the Ras-MAPK pathway. Read More

View Article
December 2008

Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.

Horm Res 2009 4;71(4):185-93. Epub 2009 Mar 4.

Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Noonan syndrome (NS) is one of the most common syndromes transmitted by a mendelian mode. In recent years, germline mutations that affect components of the RAS-MAPK (mitogen-activated protein kinase) pathway were shown to be involved in the pathogenesis of NS and four rare syndromes with clinical features overlapping with NS: Leopard syndrome, cardio-facio-cutaneous syndrome, Costello syndrome and neurofibromatosis type 1. Several hormones act through receptors that stimulate the RAS-MAPK pathway, and therefore, NS and related disorders represent a remarkable opportunity to study the implication of the RAS-MAPK pathway in different endocrine systems. Read More

View Article
June 2009

Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients.

Mol Syndromol 2013 Jun 8;4(5):227-34. Epub 2013 May 8.

Department of Pediatrics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Noonan syndrome (NS) is an autosomal dominant disorder characterized by facial dysmorphisms, short stature and congenital heart defects. The disorder is genetically heterogeneous and shows clinical overlap with other RASopathies. These syndromes are caused by mutations in a variety of genes leading to dysregulation of the RAS-MAPK pathway: PTPN11, KRAS, SOS1, RAF1, CBL, SHOC2, NRAS, BRAF, MAP2K1, MAP2K2, HRAS, NF1 and SPRED1. Read More

View Article
June 2013